Visual characterization of targeted effect of holo-transferrin-tagged dihydroartemisinin on human breast cancer cells

Chinese Science Bulletin

Volumn 55, Issue 22, 2010, Pages 2390-2395

  Xie, Wei Ling ^a   Yang, Pei Hui ^a   Zeng, Xin ^a   Wang, Hui ^a   Cai, Huai Hong ^a   Cai, Ji Ye ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

atomic force microscopy; breast cancer cells; cytotoxicity; dihydroartemisinin; holo transferrin

Indexed keywords

EID: 77955540305     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-010-3284-3     Document Type: Article

References (18)

1. Ferrari M. Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer, 2005, 5: 161-171.
2. Cattaneo R, Miest T, Shashkova E V, et al. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol, 2008, 6: 529-540.
3. Baker H M, Anderson B F, Baker E N. Dealing with iron: Common structural principles in proteins that transport iron and heme. Proc Natl Acad Sci USA, 2003, 100: 3579-3583.
4. Gomme P T, McCann K B, Bertolini J. Transferrin: Structure, function and potential therapeutic actions. Drug Discov Today, 2005, 10: 267-273.
5. Nakase I, Lai H, Singh N P, et al. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm, 2008, 354: 28-33.
6. Qian Z M, Li H Y, Sun H Z, et al. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharm Rev, 2002, 54: 561-587.
7. Efferth T, Benakis A, Romero M R, et al. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radical Bio Med, 2004, 37: 998-1009.
8. O'Neill P M. Medicinal chemistry: A worthy adversary for malaria. Nature, 2004, 430: 838-839.
9. White N J. Antimalarial drug resistance. J Clin Invest, 2004, 113: 1084-1092.
10. Meshnick S R. Artemisinin: Mechanisms of action, resistance and toxicity. Int J Parasitol, 2002, 32: 1655-1660.
11. Wiesner J, Ortmann R, Jomaa H, et al. New antimalarial drugs. Angew Chem Int Edit, 2003, 42: 5274-5293.
12. Lai H, Sasaki T, Singh N P, et al. Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci, 2005, 76: 1267-1279.
13. Parot P, Dufrene Y F, Hinterdorfer P, et al. Past, present and future of atomic force microscopy in life sciences and medicine. J Mol Recognit, 2007, 20: 418-431.
14. Horber J, Miles M J. Scanning probe evolution in biology. Science, 2003, 302: 1002-1005.
15. Lu Z X, Zhang Z L, Pang D W. Atomic force microscopy in cell biology. Chinese Sci Bull, 2005, 50: 1409-1414.
16. Zheng Z W, Yang P H, Zeng G C, et al. Probing molecular interaction between transferrin and anti-transferrin by atomic force microscope. Chinese Sci Bull, 2006, 51: 405-408.
17. Xie W L, Yang P H, Zeng X, et al. Effects of 4-(12-dihydroartemis-ininoxy) benzoic acid hydrozide-transferrin targeted drug on human breast cancer cells. Chinese J Anal Chem, 2009, 37: 671-675.
18. Cai H H, Cai J, Yang P H. Electrochemical activity of holotransferrin and its electrocatalysis-mediated process of artemisinin. Bioorg Med Chem Lett, 2009, 19: 863-866.